Fibrinogen Intravenous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fibrinogen Intravenous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fibrinogen
Brand name: RiaSTAP
Synonyms: Fibrinogen, Fibrinogen Concentrate (Human)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fibrinogen Intravenous-Insulin degludec
- Fibrinogen Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Fibrinogen Intravenous-Insulin Degludec (U-100) Vials
- Fibrinogen Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Fibrinogen Intravenous-Insulin degludec and liraglutide
- Fibrinogen Intravenous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fibryga
- Insulin aspart, recombinant Subcutaneous-Fidaxomicin
- Insulin aspart, recombinant Subcutaneous-Filgrastim
- Insulin aspart, recombinant Subcutaneous-Filgrastim Injection
- Insulin aspart, recombinant Subcutaneous-Filgrastim, Tbo-filgrastim
- Insulin aspart, recombinant Subcutaneous-Filgrastim-aafi